Sarepta Therapeutics (SRPT) Inventory Average (2016 - 2026)

Sarepta Therapeutics has reported Inventory Average for 11 years, with the latest figure at $957.9 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 13.27% year-over-year to $957.9 million; the trailing twelve-month figure through Mar 2026 stood at $957.9 million (up 13.27% YoY), and the FY2025 full-year result was $832.4 million, up 55.17% from the prior year.
• Inventory Average for Q1 2026 stood at $957.9 million, down from $996.0 million in the prior quarter.
• The five-year high for Inventory Average was $1.0 billion in Q3 2025, with the low at $192.6 million in Q1 2022.
• Average Inventory Average over 5 years is $501.5 million, with a median of $348.2 million recorded in 2024.
• Year-over-year, Inventory Average dropped 22.96% in 2022 and jumped 142.88% in 2025.
• Tracing SRPT's Inventory Average over 5 years: stood at $212.6 million in 2022, then surged by 33.33% to $283.4 million in 2023, then jumped by 132.13% to $657.9 million in 2024, then jumped by 51.37% to $996.0 million in 2025, then slipped by 3.82% to $957.9 million in 2026.
• The last three Inventory Average figures came in at $957.9 million (Q1 2026), $996.0 million (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.

Peer Comparison